Drug profile · INN
etrasimod arginine
VELSIPITY
etrasimod arginine (VELSIPITY) is a sphingosine 1-phosphate receptor edg-6 modulator. Route of administration: oral. Current US regulatory status: approved.
Drug details — etrasimod arginine
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 5
- Data quality
- 0.84
Quick answer
etrasimod arginine (VELSIPITY) is a sphingosine 1-phosphate receptor edg-6 modulator. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Sphingosine 1-phosphate receptor Edg-6 modulator
Primary target: Sphingosine 1-phosphate receptor 1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is etrasimod arginine?
etrasimod arginine (VELSIPITY) is a sphingosine 1-phosphate receptor edg-6 modulator. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for etrasimod arginine?
VELSIPITY is a marketed brand name for etrasimod arginine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of etrasimod arginine?
etrasimod arginine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.